Pharmacological chaperones stabilize retromer to limit APP processing

In silico screening identifies a small molecule that stabilizes the interaction between retromer components Vps35 and Vps29. The compound increases traffic of APP away from the endosomal compartment to limit generation of the Aβ peptides involved in Alzheimer's disease pathology.